BioVersys brings Sfr80m Swiss IPO for new antibiotics

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity

BioVersys brings Sfr80m Swiss IPO for new antibiotics

Arthur Bautzer
January 21, 2025 05:42 pm
Decision follows successful Phase 2 trial on ICU patients last year

Decision follows successful Phase 2 trial on intensive care patients

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityEquity IPOsHealth and Biotech
AB
Arthur Bautzer
Gift this article